TheraCryf (LSE:TCF) FCF Yield %: -36.77 (As of Jun. 28, 2026)


What is TheraCryf FCF Yield %?

TheraCryf LSE:TCF -8.51% FCF Yield % is -36.77 as of Jun. 28, 2026. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, TheraCryf ranks worse than 76.87% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, TheraCryf's Trailing 12-Month Free Cash Flow is £-1.70 Mil, and Market Cap is £4.62 Mil. Therefore, TheraCryf's FCF Yield % for today is -36.77%.

The historical rank and industry rank for TheraCryf's FCF Yield % or its related term are showing as below:

LSE:TCF' s FCF Yield % Range Over the Past 10 Years
Min: -573.63   Med: -83.43   Max: -22.32
Current: -36.77

During the past 13 years, the highest FCF Yield % of TheraCryf was -22.32%. The lowest was -573.63%. And the median was -83.43%.

LSE:TCF's FCF Yield % is ranked worse than
76.87% of 1418 companies
in the Biotechnology industry
Industry Median: -9.715 vs LSE:TCF: -36.77

TheraCryf's FCF Margin % for the quarter that ended in Sep. 2025 was 0.00%.

TheraCryf FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

TheraCryf FCF Yield % Related Terms

TheraCryf FCF Yield % Historical Data

* Premium members only.

The historical data trend for TheraCryf's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf FCF Yield % Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.31 -26.89 -40.59 -124.56 -49.40

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.07 -143.35 -86.67 -40.82 -31.21

LSE:TCF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, TheraCryf's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's FCF Yield % distribution charts can be found below:

* The bar in red indicates where TheraCryf's FCF Yield % falls into.


TheraCryf FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

TheraCryf's FCF Yield % for the fiscal year that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.367 / 4.7916495
=-49.40%

TheraCryf's annualized FCF Yield % for the quarter that ended in Sep. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.721 * 2 / 4.6202726
=-31.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -36.77 mean?
TheraCryf (LSE:TCF) has a FCF Yield % of -36.77 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TheraCryf and its competitors. According to the industry distribution chart, TheraCryf ranks #1090 out of 1418 companies in the Biotechnology industry, placing it in the top 76.9%.
Is TheraCryf's FCF Yield % too high?
TheraCryf's current FCF Yield % is -36.77. Based on the distribution chart, TheraCryf ranks #1090 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does TheraCryf's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TheraCryf ranks #1090 out of 1418 companies for FCF Yield %. This places TheraCryf in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TheraCryf and its competitors. TheraCryf's current FCF Yield % is -36.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current FCF Yield % of -36.77. The current FCF Yield % is -36.77. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current FCF Yield % is -36.77 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.